Dee Sparacio: QI Initiative Reduces Venous Thromboembolism in First-Line Ovarian Cancer Care
Dee Sparacio, Research Advocate, shared a post on X about a recent article by Limor Helpman et al., published in Gynecologic Oncology, adding:
“Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer– A quality improvement project; gyncsm oral anticoagulation QI program successfully decreased VTE events during first-line chemotherapy for OC.”
Title: Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer– A quality improvement project
Authors: Limor Helpman, Dana Josephy, Liat Toderis, Victoria Tkach, Noa Rotem, Daniel Shai, Sonya Bar-Adon, Hadas Heger, Yfat Kadan, Ana Blecher, Orgad Rosenblatt, Itai Yagel, Danielle Mor-Hadar, Keren Levanon, Ronnie Shapira-Frommer, Akram Saad, Smadar Bauer, Sara Apter, Tima Davidson, Aaron Lubetsky, Jacob Korach
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 2, 2026, 09:20Anticoagulants, Blood Thinners, or Antithrombotic Medications? – World Thrombosis Day
-
Oct 2, 2026, 06:00Susan Wickersham: Gradual Shift towards Autologous Blood Transfusion is a Current Trend
-
Oct 2, 2026, 05:54Shamee Shastry: When Every Cell Reacts – The Hunt for Rare Blood
-
Oct 2, 2026, 05:49David Mclntosh: Expanding Plasma Protein Therapies in Underserved Regions
-
Oct 2, 2026, 05:38Dianne E. van der Wal: C-Terminal Endings Impact PAR1/PAR4 Peptide Potency in In Vitro Platelet Assays
-
Oct 2, 2026, 05:29Mohammed Alo: Your LDL Isn’t a Snapshot – It’s a Smoking Habit Measured in Years
-
Oct 2, 2026, 00:33Marwa Mostafa: Hemoglobinopathies – When Globin Genes Go Wrong
-
Oct 1, 2026, 23:46Behnood Bikdeli: Global Burden of Venous Thromboembolism
-
Oct 1, 2026, 23:46Sthanu Subramanian: Clinical Presentation, Risk Factors, Diagnosis, and Neuroimaging Findings in CVT